Zobrazeno 1 - 10
of 25
pro vyhledávání: '"MONICA MOSSENTA"'
Autor:
Davide Busato, Sara Capolla, Paolo Durigutto, Monica Mossenta, Sara Bozzer, Daniele Sblattero, Paolo Macor, Michele Dal Bo, Giuseppe Toffoli
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers with a very low survival rate at 5 years. The use of chemotherapeutic agents results in only modest prolongation of survival and is generally associated
Externí odkaz:
https://doaj.org/article/da4516817faf461f9882e4337173d4b5
Autor:
Jose L Slon Campos, Monica Poggianella, Sara Marchese, Monica Mossenta, Jyoti Rana, Francesca Arnoldi, Marco Bestagno, Oscar R Burrone
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181734 (2017)
Dengue virus (DENV), the causative agent of dengue disease, is among the most important mosquito-borne pathogens worldwide. DENV is composed of four closely related serotypes and belongs to the Flaviviridae family alongside other important arthropod-
Externí odkaz:
https://doaj.org/article/8f906b84a3984196a339bfef7ea08456
Publikováno v:
International journal of molecular sciences. 23(18)
Pancreatic ductal adenocarcinoma (PDAC) accounts for 90% of all pancreatic cancers, with a 5-year survival rate of 7% and 80% of patients diagnosed with advanced or metastatic malignancies. Despite recent advances in diagnostic testing, surgical tech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16aad6d062d8dbad0961dd9806ffc8c1
https://pubmed.ncbi.nlm.nih.gov/36142190
https://pubmed.ncbi.nlm.nih.gov/36142190
Autor:
Michele Dal Bo, Davide Busato, Federica Di Cintio, Monica Mossenta, Lorena Baboci, Giuseppe Toffoli
Publikováno v:
Expert Review of Clinical Pharmacology. 12:453-470
The introduction of immune checkpoint inhibitors has been lately proposed for the treatment of hepatocellular carcinoma (HCC) with respect to other cancer types. Several immunotherapeutic approaches are now under evaluation for HCC treatment includin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251ca307fc8eecc9f90d43540ffc8e0c
https://doi.org/10.1080/17512433.2019.1598859
https://doi.org/10.1080/17512433.2019.1598859
Publikováno v:
International Journal of Molecular Sciences. 23:10038
Hepatocellular carcinoma (HCC) is the second most lethal tumor, with a 5-year survival rate of 18%. Early stage HCC is potentially treatable by therapies with curative intent, whereas chemoembolization/radioembolization and systemic therapies are the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc01d0540cdf386f9118b9cc98d8e20
https://doi.org/10.3390/ijms231710038
https://doi.org/10.3390/ijms231710038
Autor:
Giuseppe Toffoli, Davide Busato, Monica Mossenta, Luca Bedon, Michele Dal Bo, Maurizio Polano
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 1075, p 1075 (2021)
Volume 22
Issue 3
International Journal of Molecular Sciences, Vol 22, Iss 1075, p 1075 (2021)
Volume 22
Issue 3
Although extensive advancements have been made in treatment against hepatocellular carcinoma (HCC), the prognosis of HCC patients remains unsatisfied. It is now clearly established that extensive epigenetic changes act as a driver in human tumors. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8837ee1d0357b11731110872f77e476f
http://europepmc.org/articles/PMC7865606
http://europepmc.org/articles/PMC7865606
Publikováno v:
Cancers, Vol 12, Iss 1668, p 1668 (2020)
Cancers
Cancers
Hepatocellular carcinoma (HCC) metabolism is redirected to glycolysis to enhance the production of metabolic compounds employed by cancer cells to produce proteins, lipids, and nucleotides in order to maintain a high proliferative rate. This mechanis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea2c035cfdfe17385bb39a41b67582b
https://www.mdpi.com/2072-6694/12/6/1668
https://www.mdpi.com/2072-6694/12/6/1668
Autor:
Marco Bestagno, Oscar R. Burrone, J. L. Slon Campos, Monica Poggianella, Monica Mossenta, Jyoti Rana, S. Marchese
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Scientific Reports
Scientific Reports
Dengue and Zika are two of the most important human viral pathogens worldwide. In both cases, the envelope glycoprotein E is the main target of the antibody response. Recently, new complex quaternary epitopes were identified which are the consequence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b4fe7669a7f3d9a7b1fce8b5d15f601
https://ora.ox.ac.uk/objects/uuid:5b1c7065-65f8-4d9a-81e8-8f0067c9492a
https://ora.ox.ac.uk/objects/uuid:5b1c7065-65f8-4d9a-81e8-8f0067c9492a
Autor:
Francesca Arnoldi, Marco Bestagno, Jyoti Rana, Oscar R. Burrone, Sara Marchese, José L. Slon Campos, Monica Poggianella, Monica Mossenta
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 7, p e0181734 (2017)
PLoS ONE, Vol 12, Iss 7, p e0181734 (2017)
Dengue virus (DENV), the causative agent of dengue disease, is among the most important mosquito-borne pathogens worldwide. DENV is composed of four closely related serotypes and belongs to the Flaviviridae family alongside other important arthropod-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be51755d5ff8071004004293e05cd39
https://pubmed.ncbi.nlm.nih.gov/28742857
https://pubmed.ncbi.nlm.nih.gov/28742857
Publikováno v:
Biochemical and biophysical research communications. 492(4)
Zika virus has rapidly spread reaching a global distribution pattern similar to that of dengue virus, and has been associated with serious neurological and developmental pathologies, like congenital malformation during pregnancy and Guillain-Barré s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910ed03ecf89876a9ef045450521e854
https://pubmed.ncbi.nlm.nih.gov/28069378
https://pubmed.ncbi.nlm.nih.gov/28069378